Stock VISTN VISTIN PHARMA ASA
Add to a list
To use this feature you must be a member
Log inSign up

Company Vistin Pharma ASA

Equities

VISTN

NO0010734122

Pharmaceuticals

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-04-26 am EDT 		5-day change 1st Jan Change
23.9 NOK +1.70% Intraday chart for Vistin Pharma ASA 0.00% +2.58%
Apr. 24 Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 24 Transcript : Vistin Pharma ASA, Q1 2024 Earnings Call, Apr 24, 2024

Business Summary

Vistin Pharma ASA is a Norway-based holding company, which operates through its subsidiary Vistin Pharma AS. The Company is engaged in the pharmaceuticals industry. The Company is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.

Number of employees: 78

Sales per Business

NOK in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
288 100.0 % 435 100.0 % +51.35%

Sales per region

NOK in Million2022Weight2023Weight Delta
Europe
77.8 %
196 68.1 % 339 77.8 % +72.91%
Africa
15.1 %
37 13.0 % 66 15.1 % +75.29%
Asia
6.7 %
20 6.9 % 29 6.7 % +48.11%
North and South America
0.3 %
34 12.0 % 2 0.3 % -95.63%

Managers

Managers TitleAgeSince
Magnus Tolleshaug CEO
 Chief Executive Officer - 20-02-29
Alexander Karlsen DFI
 Director of Finance/CFO - 20-03-01
Eivind Egeli CTO
 Chief Tech/Sci/R&D Officer - 15-05-31
Vegard Heggem PRN
 Corporate Officer/Principal - 15-05-31
Sabrina Berge PRN
 Corporate Officer/Principal - 15-05-31
Hilde Merete Hagen LAW
 General Counsel - 15-02-28

Members of the board

Members of the board TitleAgeSince
Øyvin Anders Brøymer CHM
 Chairman 76 20-05-31
Øystein Stray Spetalen BRD
 Director/Board Member 62 15-03-05
Kari Eian Krogstad BRD
 Director/Board Member 60 -
Bettina Banoun BRD
 Director/Board Member 52 18-05-07
Åse Musum BRD
 Director/Board Member - 15-05-31
Espen Weyergang Marcussen BRD
 Director/Board Member - 20-05-03
Espen Lia Gregoriussen BRD
 Director/Board Member - 16-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 44,344,592 20,062,899 ( 45.24 %) 0 45.24 %

Shareholders

NameEquities%Valuation
Øyvin Anders Brøymer
28.36 %
12,575,000 28.36 % 26 M kr
Holmen Fondsforvaltning AS
7.938 %
3,520,243 7.938 % 7 M kr
Astrup Family
7.937 %
3,519,733 7.937 % 7 M kr
MP Pensjon PK
3.878 %
1,719,848 3.878 % 4 M kr
Øystein Stray Spetalen
2.783 %
1,234,280 2.783 % 3 M kr
Dag F Jebsen Arnesen
1.694 %
751,000 1.694 % 2 M kr
Ringvold Family
1.692 %
750,315 1.692 % 2 M kr
Lucellum AS
1.624 %
720,000 1.624 % 1 M kr
Henrik Midttun Haavie
1.324 %
587,334 1.324 % 1 M kr
Ivar Løges Stiftelse
1.240 %
550,000 1.240 % 1 M kr

Company contact information

Vistin Pharma ASA

Østensjøveien 27

0661, Oslo

+47 35 98 42 00

http://www.vistin.com
address Vistin Pharma ASA(VISTN)

Group companies

NameCategory and Sector
Vistin Trading AS
Logo Vistin Trading AS

Vistin Trading AS

Finance/Rental/LeasingFinance

Part of Vistin Pharma ASA, Vistin Trading AS offers trade in financial instruments and other investments. The private company is based in Oslo, Norway.

Finance/Rental/Leasing
Vistin Pharma AS
Logo Vistin Pharma AS

Vistin Pharma AS

Pharmaceuticals: MajorHealth Technology

Part of Vistin Pharma ASA, Vistin Pharma is a leading European metformin producer supplying to international pharmaceutical companies. The private company is located in Norway. Metformin is a standard first-line treatment for type 2 diabetes. The Norwegian company believes in balancing business growth with environmental sustainability, social responsibility, and ethical business practices.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
VISTIN PHARMA ASA Stock Vistin Pharma ASA
+2.58% 95.97M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VISTN Stock
  4. Company Vistin Pharma ASA